These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula. Dhahri M, Mansour MB, Bertholon I, Ollivier V, Boughattas NA, Hassine M, Jandrot-Perrus M, Chaubet F, Maaroufi RM. Blood Coagul Fibrinolysis; 2010 Sep 10; 21(6):547-57. PubMed ID: 20581662 [Abstract] [Full Text] [Related]
48. Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin. Hoppensteadt DA, Walenga JM, Fareed J. Semin Thromb Hemost; 1991 Sep 10; 17 Suppl 1():60-4. PubMed ID: 2068572 [Abstract] [Full Text] [Related]
49. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II]. Zhang G. Zhonghua Xue Ye Xue Za Zhi; 1997 Mar 10; 18(3):126-9. PubMed ID: 15622771 [Abstract] [Full Text] [Related]
50. Osmotic stress regulates the anticoagulant efficiency of dermatan sulfate. McGee MP, Wagner W, Li L. Matrix Biol; 2004 Oct 10; 23(6):363-70. PubMed ID: 15533757 [Abstract] [Full Text] [Related]
51. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation. Tran TH, Duckert F. Thromb Haemost; 1984 Oct 31; 52(2):112-6. PubMed ID: 6395434 [Abstract] [Full Text] [Related]
52. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin. Meddahi S, Bara L, Fessi H, Samama MM. Blood Coagul Fibrinolysis; 2000 Jan 31; 11(1):51-9. PubMed ID: 10691099 [Abstract] [Full Text] [Related]
53. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. Andrew M, Mitchell L, Berry L, Paes B, Delorme M, Ofosu F, Burrows R, Khambalia B. J Clin Invest; 1992 Jan 31; 89(1):321-6. PubMed ID: 1729278 [Abstract] [Full Text] [Related]
54. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation. Wagenvoord R, Hendrix H, Soria C, Hemker HC. Thromb Haemost; 1988 Oct 31; 60(2):220-5. PubMed ID: 2464199 [Abstract] [Full Text] [Related]
55. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082. Ofosu FA, Fareed J, Smith LM, Anvari N, Hoppensteadt D, Blajchman MA. Eur J Biochem; 1992 Jan 15; 203(1-2):121-5. PubMed ID: 1730217 [Abstract] [Full Text] [Related]
56. Anticoagulant properties of a fucoïdan fraction. Colliec S, Fischer AM, Tapon-Bretaudiere J, Boisson C, Durand P, Jozefonvicz J. Thromb Res; 1991 Oct 15; 64(2):143-54. PubMed ID: 1811335 [Abstract] [Full Text] [Related]
57. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va. Van Walderveen MC, Berry LR, Atkinson HM, Chan AK. Thromb Haemost; 2010 May 15; 103(5):910-9. PubMed ID: 20216984 [Abstract] [Full Text] [Related]
58. Effects of glycosaminoglycans and protamine chloridrate on platelet aggregation induced by collagen and thrombin. Luzzatto G, Paolini R, Stevanato F, Simioni P, Cella G. Angiology; 1989 Mar 15; 40(3):170-4. PubMed ID: 2916768 [Abstract] [Full Text] [Related]
59. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides. Wun TC. Blood; 1992 Jan 15; 79(2):430-8. PubMed ID: 1346095 [Abstract] [Full Text] [Related]
60. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C. Fernández JA, Petäjä J, Griffin JH. Thromb Haemost; 1999 Nov 15; 82(5):1462-8. PubMed ID: 10595639 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]